Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01015755 · ClinicalTrials.gov registry record · Early Phase 1
Palliation of Thirst in ICU Patients
A Early Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 353
- Enrollment target
NCT01015755: Completed Early Phase 1 study, sponsored by University of California, San Francisco.
NCT01015755 is a Early Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 353 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (566% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01015755, a Early Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 353 participants
- Enrollment target
Study Summary
Patients in Intensive Care Units are often extremely thirsty due to their medicines, illness, treatments or medicines that they receive. This study will test whether patients who receive a easy to implement intervention for thirst will have greater relief from thirst than a group of patients who do not receive the intervention. The study will also identify the most important factors that make ICU patients thirsty so that future research studies can test how to relieve those factors and/or make interventions for thirst more readily available.
Interventions
- BEHAVIORAL combined therapy treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-07 |
| Phase | Early Phase 1 |
What the finished NCT01015755 record still lists
NCT01015755 is an interventional study that assigns participants to a tested intervention. The registered 353 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (566% higher).
The record links to 0 conditions, and to 1 intervention - of which combined therapy treatment is the first listed.
NCT01015755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01015755 about?
NCT01015755 is a clinical study titled "Palliation of Thirst in ICU Patients". Patients in Intensive Care Units are often extremely thirsty due to their medicines, illness, treatments or medicines that they receive. This study will test whether patients who receive a easy to implement intervention for thirst will have greater relief from thirst than a group of patients who do ...
What is the current status of trial NCT01015755?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 353 participants. The study started on 2010-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01015755?
The interventions under investigation include: combined therapy treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01015755?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01015755's enrollment target sits among peer trials
353 30th of 2000 higher than 1,971 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05548296 · 353 participants · Phase 2
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- NCT05884775 · 353 participants · NA
Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia